The University of Florida Department of Urology invites you to attend Grand Rounds:
Wednesday, May 26, 2021 7:00 – 8:00 AM
Urology Conference Room M-203C
*Please adhere to UF Social Distancing Guidelines
“Risk of Metachronous Upper Tract Urothelial Cell Carcinoma in Bladder Cancer Patients“
Presenter: Hiroko Miyagi, MD
University of Florida
Department of Urology
Upon completion of this activity, participants should be able to:
1. Review risk factors for the development of upper tract urothelial cell cancer in bladder cancer patients
2. Review the hypotheses for development of metachronous UTUCC development
3. Define the rate of ureteral orifice stricture after TURBT
4. Review current guidelines for upper tract surveillance in bladder cancer patients
Urologists, Residents, Nurses, Physician Assistants, and Staff
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event which is internally supported.
If you have any questions please feel free to contact Stephanie Stenner at Stephanie.email@example.com.
Dr. Miyagi has disclosed that he has no relevant financial relationships. Dr. Vincent Bird, Planning Committee, is a consultant for Boston Scientific. No one else in a position to control content has any financial relationship to disclose.
Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/.
Section Number: 1254